Clinical determinants and prognostic value of hemoglobin in hospitalized patients with systolic heart failure;Determinantes clínicos y valor pronóstico de la hemoglobina en pacientes hospitalizados con insuficiencia cardiaca sistólica

Revista Espanola de Cardiologia

Volumn 60, Issue 6, 2007, Pages 597-606

  Redondo Bermejo, Belén ^a   Pascual Figal, Domingo A ^a   Hurtado Martínez, José A ^a   Montserrat Coll, Jorge ^a   Peñafiel Verdú, Pablo ^a   Pastor Pérez, Francisco ^a   Giner Caro, José A ^a   Valdés Chávarri, Mariano ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Anemia; Heart failure; Hemoglobin; Prognosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIGOXIN; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; UREA; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN DETERMINATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SYSTOLIC HEART FAILURE; UREA BLOOD LEVEL; ANEMIA; BLOOD; FORWARD HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; KAPLAN MEIER METHOD; MIDDLE AGED; SYSTOLE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CARDIAC OUTPUT, LOW; FEMALE; HEMOGLOBINS; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34347236198     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13107116     Document Type: Article

References (31)

1. Rodríguez-Artalejo F, Banegas B Jr, Guallar-Castillon P. Epidemiología de la insuficiencia cardiaca. Rev Esp Cardiol. 2004;57:163-70.
2. Rich MW, Nease RF. Cost-effectiveness analysis in clinical practice: the case of heart failure. Arch Intern Med. 1999;159:1690-700.
3. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-5.
4. McAlister FA, Lawson FM, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. Am J Med. 2001;110:378-84.
5. Komajda M. Prevalence of anemia in patients with chronic heart failure and their clinical characteristics. J Card Fail. 2004;10:S1-S4.
6. Maggioni AP, Opasich C, Anand I, Barlera S, Carbonieri E, Gonzini L, et al. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail. 2005;11:91-8.
7. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-6.
8. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955-62.
9. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107:223-5.
10. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110:149-54.
11. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation. 2006;113:986-94.
12. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-9.
13. Horl WH, Ertl G. Anaemia and the heart. Eur J Clin Invest. 2005;35:20-5.
14. Okonko DO, Anker SD. Anemia in chronic heart failure: pathogenetic mechanisms. J Card Fail. 2004;10:S5-S9.
15. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol. 2003;41:1933-9.
16. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527-60.
17. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-40.
18. O'Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh TA. The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail. 2006;8:63-7.
19. Iversen PO, Woldbaek PR, Tonnessen T, Christensen G. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol. 2002;282:R166-R72.
20. Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, Hester A, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation. 2005;112:1121-7.
21. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-6.
22. Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, Hester A, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation. 2005;112:1121-7.
23. Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005;45:391-9.
24. Lupon J, Urrutia A, González B, Herreros J, Altimir S, Coll R, et al. Significado pronóstico de los valores de hemoglobina en pacientes con insuficiencia cardiaca. Rev Esp Cardiol. 2005;58:48-53.
25. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53-61.
26. Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15:14-8.
27. Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol. 2004;44:959-66.
28. Grigorian-Shamagian L, Varela-Román A, Mazón-Ramos P, Pedreira-Pérez M, Rigueiro-Veloso P, González-Juanatey JR. Anemia como nuevo predictor de la mortalidad de pacientes hospitalizados por insuficiencia cardiaca congestiva. Med Clin (Barc). 2005;625:647-52.
29. Sánchez-Torrijos J, Gudin-Uriel M, Nadal-Barangué M, Jacas-Osborn V, Trigo-Bautista A, Jiménez-Alcala M, et al. Valor pronóstico de las cifras de hemoglobina en el momento del alta en pacientes hospitalizados por insuficiencia cardiaca. Rev Esp Cardiol. 2006;59:1276-82.
30. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775-80.
31. Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294-9.